Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Nabriva Therapeutics (NBRVF) Q1 2022 Earnings
NBRVF
5
May
Expected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.35
-0.29
-0.24
-0.19
Details
Expected EPS
-0.19
Actual EPS
-0.2
Surprise EPS
-0.01
Surprise Percent
+5.26%
Description
Nabriva Therapeutics (NBRVF) has reported earnings of -0.2 per share for Q1 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login